BMC Health Services Research · 2019 · 16 citations · 13 references
PharmacyCommunity PharmacyPharmacy PracticePharmaceutical CarePharmacy AdministrationPublic Health PharmacyMedication ManagementMedication ReviewMedication SafetyMedication Therapy ManagementMedication Use EvaluationPharmacist ResponsibilitiesDrug ReviewMedication Safety ScreeningMedication Therapy ReviewMedication-related Problem AnalysisPharmacist-led Medication ReviewPharmacy Medication SafetyPrimary Care Medication ReviewVitamin K Antagonist Therapy
BACKGROUND: Pharmaceutical care is the pharmacist's contribution to the care of individuals to optimize medicines use and improve health outcomes. The primary tool of pharmaceutical care is medication review. Defining and classifying Drug-Related Problems (DRPs) is an essential pillar of the medication review. Our objectives were to perform a pilot of medication review in Hungarian community pharmacies, a DRP classification was applied for the first time. Also, our goal was the qualitative and quantitative description of the discovered DRPs, and of the interventions for their solution in order to prove the safety relevance of the service and to map out the competence limits of GPs and community pharmacists to drug therapy. METHODS: The project took place in Hungarian community pharmacies. The study was performed with patients taking vitamin K antagonist (VKA) and/or ACE inhibitor and NSAID simultaneously (ACEI-NSAID). 61 pharmacists and 606 patients participated in the project. Pharmacists reviewed the medication for 3 months and the classification of DRPs was performed (category of DRP1 - DRP6). Patient data were statistically analyzed. RESULTS: Patients consumed on average 7.9 ± 3.1 medications and other products. 571 DRPs were detected in 540 patients, averaging 1.06 DRPs per patient (SD = 1.07). The highest frequency category was DRP5 (non-quantitative safety problem; 51.0%). The most common root cause was an interaction (42.0%) and non-adherence (19.4%.). The most commonly used intervention was education (25.4%) and medication replacement by the pharmacist (20.1%). The changing of the frequency and dosage in any direction were negligible. CONCLUSIONS: Patients are struggling with many DRPs that can be assessed and categorized by this system and which remain unrecognizable without pharmacists. Further projects need to be developed to assist in the development of physician-pharmacist cooperation and the widespread dissemination of pharmaceutical care.
13
NSAID Use and Progression of Chronic Kidney Disease
Katherine Gooch, Bruce F. Culleton, Braden Manns et al. · The American Journal of Medicine · 2007 · 336 citations · Full text
Pharmaceutical Care: the PCNE definition 2013
Samuel Allemann, J. W. Foppe van Mil, Lea Botermann et al. · International Journal of Clinical Pharmacy · 2014 · 219 citations
Markus Messerli, Eva Blozik, Noortje Vriends et al. · BMC Health Services Research · 2016 · 125 citations · Full text